相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
Temitope Foster et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease
Kristin D. Kistler et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Effect of antioxidant supplementation on insulin sensitivity in response to endurance exercise training
Christina Yfanti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Obesity, diabetes mellitus, and liver fibrosis
Dian J. Chiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Giovanni Musso et al.
ANNALS OF MEDICINE (2011)
Interactions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes
Giovanni Musso et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities
Roberto Gambino et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial
Valerio Nobili et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2011)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes
P. K. Shah et al.
DIABETES OBESITY & METABOLISM (2011)
Combined cardiovascular and diabetes risk assessment in primary care
D. Preiss et al.
DIABETIC MEDICINE (2011)
Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
Kate Hallsworth et al.
GUT (2011)
Need for a Three-Focused Approach to Nonalcoholic Fatty Liver Disease
Giovanni Musso et al.
HEPATOLOGY (2011)
Randomized Comparison of Reduced Fat and Reduced Carbohydrate Hypocaloric Diets on Intrahepatic Fat in Overweight and Obese Human Subjects
Sven Haufe et al.
HEPATOLOGY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period
Ayaka Hamabe et al.
JOURNAL OF GASTROENTEROLOGY (2011)
TREATMENT OF NONALCOHOLIC STEATOHEPATITIS WITH PROBIOTICS - A PROOF-OF-CONCEPT STUDY WITH SERIAL GUT MICROBIOTA ANALYSIS BY ULTRA-DEEP SEQUENCING
V. W. -S. Wong et al.
JOURNAL OF HEPATOLOGY (2011)
EFFICACY OF EZETIMIBE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED, CONTROLLED TRIAL
Y. Takeshita et al.
JOURNAL OF HEPATOLOGY (2011)
DISSOCIATED HISTOLOGICAL AND METABOLIC EFFECTS OF OMEGA-3 (3000 MG/D) VERSUS PLACEBO WITH BOTH EXERCISE AND DIET IN A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF NASH
S. H. Caldwell et al.
JOURNAL OF HEPATOLOGY (2011)
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2011)
Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
Claudia O. Zein et al.
JOURNAL OF HEPATOLOGY (2011)
Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial
Elena Sofer et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals
Rasmus Rabol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?
Filip K. Knop
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease
Giovanni Musso et al.
ANNUAL REVIEW OF MEDICINE (2010)
Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic Syndrome
Sridevi Devaraj et al.
CURRENT ATHEROSCLEROSIS REPORTS (2010)
Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes
Mariana Lazo et al.
DIABETES CARE (2010)
Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes
Jacqueline T. Jonker et al.
DIABETES CARE (2010)
Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
Dick C. Chan et al.
DIABETES CARE (2010)
Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
Ziya Omer et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
Kittichai Promrat et al.
HEPATOLOGY (2010)
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) Extension Trial
Vlad Ratziu et al.
HEPATOLOGY (2010)
Smoking Is Associated with Histological Severity in Nonalcoholic Steatohepatitis
Emmanuel A. Tsochatzis et al.
HEPATOLOGY (2010)
Increased Fructose Consumption Is Associated with Fibrosis Severity in Patients with Nonalcoholic Fatty Liver Disease
Manal F. Abdelmalek et al.
HEPATOLOGY (2010)
Liver Enzymes, Nonalcoholic Fatty Liver Disease, and Incident Cardiovascular Disease: A Narrative Review and Clinical Perspective of Prospective Data
Nazim Ghouri et al.
HEPATOLOGY (2010)
High-Dose Ursodeoxycholic Acid Therapy for Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Trial
Ulrich F. H. Leuschner et al.
HEPATOLOGY (2010)
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Giovanni Musso et al.
HEPATOLOGY (2010)
The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis
Mustafa S. Ascha et al.
HEPATOLOGY (2010)
The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review
Kota J. Reddy et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2010)
Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver Disease
Elisa Fabbrini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes
Alok K. Gupta et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2010)
Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development (vol 52, pg 72, 2010)
Shingo Nakamoto et al.
JOURNAL OF HEPATOLOGY (2010)
Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease
James Frith et al.
JOURNAL OF HEPATOLOGY (2010)
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Antioxidant Supplementation Does Not Alter Endurance Training Adaptation
Christina Yfanti et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
A. Nar et al.
ACTA DIABETOLOGICA (2009)
Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease
E. Vilar Gomez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes
Kim-Anne Le et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Effect of Rimonabant on the High-Triglyceride/Low-HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat The ADAGIO-Lipids Trial
Jean-Pierre Despres et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
J. Jendle et al.
DIABETES OBESITY & METABOLISM (2009)
Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients
Helma P. Cotrim et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Dietary Fat and Carbohydrates Differentially Alter Insulin Sensitivity During Caloric Restriction
Erik Kirk et al.
GASTROENTEROLOGY (2009)
Orlistat for Overweight Subjects with Nonalcoholic Steatohepatitis: A Randomized, Prospective Trial
Stephen A. Harrison et al.
HEPATOLOGY (2009)
Importance of Changes in Adipose Tissue Insulin Resistance to Histological Response During Thiazolidinedione Treatment of Patients with Nonalcoholic Steatohepatitis
Amalia Gastaldelli et al.
HEPATOLOGY (2009)
Independent Effects of Physical Activity in Patients with Nonalcoholic Fatty Liver Disease
Alexis St. George et al.
HEPATOLOGY (2009)
Betaine for Nonalcoholic Fatty Liver Disease: Results of a Randomized Placebo-Controlled Trial
Manal F. Abdelmalek et al.
HEPATOLOGY (2009)
Aerobic Exercise Training Reduces Hepatic and Visceral Lipids in Obese Individuals Without Weight Loss
Nathan A. Johnson et al.
HEPATOLOGY (2009)
Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
Andrea J. Cussons et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic Steatohepatitis A Randomized Placebo-controlled Trial
Austin Nelson et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease
Yasuji Arase et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
Yuichi Nozaki et al.
JOURNAL OF HEPATOLOGY (2009)
EFFECTS OF FENOFIBRATE AND LONG-ACTING NICOTINIC ACID ON INTRAHEPATIC TRIGLYCERIDE CONTENT AND ADIPOSE TISSUE INSULIN SENSITIVITY IN OBESE HUMAN SUBJECTS
K. Korenblat et al.
JOURNAL OF HEPATOLOGY (2009)
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Curtis K. Argo et al.
JOURNAL OF HEPATOLOGY (2009)
Diet and Exercise Interventions Reduce Intrahepatic Fat Content and Improve Insulin Sensitivity in Obese Older Adults
Krupa Shah et al.
OBESITY (2009)
Antioxidants prevent health-promoting effects of physical exercise in humans
Michael Ristow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol
Kenichiro Yasutake et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
John Willy Haukeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis
Eugen Florin Georgescu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trial
William W. Shields et al.
Therapeutic Advances in Gastroenterology (2009)
Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis
R. Idilman et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage
Ranganath Muniyappa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Soft drink consumption linked with fatty liver in the absence of traditional risk factors
Nimer Assy et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
L. Spadaro et al.
DIGESTIVE AND LIVER DISEASE (2008)
Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice
Shuqin Zheng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Rosiglitazone for nonalcoholic steatohepatitis: One-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial
Vlad Ratziu et al.
GASTROENTEROLOGY (2008)
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Guruprasad P. Aithal et al.
GASTROENTEROLOGY (2008)
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial
Valerio Nobili et al.
HEPATOLOGY (2008)
Role of Leisure-Time Physical Activity in Nonalcoholic Fatty Liver Disease: A Population-Based Study
Shira Zelber-Sagi et al.
HEPATOLOGY (2008)
Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease
Winston Dunn et al.
HEPATOLOGY (2008)
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
Kristiaan Wouters et al.
HEPATOLOGY (2008)
A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)
Yin-Mei Lee et al.
HEPATOLOGY INTERNATIONAL (2008)
The Effect of a Probiotic on Hepatic Steatosis
Steven F. Solga et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Xiaosen Ouyang et al.
JOURNAL OF HEPATOLOGY (2008)
Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia
Feng-Shang Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome
Michiyo Deushi et al.
FEBS LETTERS (2007)
Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study
Shira Zelber-Sagil et al.
JOURNAL OF HEPATOLOGY (2007)
The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis
Glen Lutchman et al.
HEPATOLOGY (2007)
What is the best predictor of future type 2 diabetes?
Muhammad A. Abdul-Ghani et al.
DIABETES CARE (2007)
Habitual physical activity is associated with intrahepatic fat content in humans
Gianluca Perseghin et al.
DIABETES CARE (2007)
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials
John B. Buse et al.
CLINICAL THERAPEUTICS (2007)
The effect of a silybin-vitamin E-phospholipid complex on nonalcoholic fatty liver disease: A pilot study
Carmela Loguercio et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis
Jean-Francois Dufour et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
Shira Zelber-Sagi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
Vasilios G. Athyros et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
An assessment of statin safety by hepatologists
DE Cohen et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice
XK Ding et al.
HEPATOLOGY (2006)
Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population
CE Ruhl et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis
G Musso et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
E Bugianesi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality
ER Miller et al.
ANNALS OF INTERNAL MEDICINE (2005)
Metformin in the treatment of patients with non-alcoholic steatohepatitis
A Uygun et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
KD Lindor et al.
HEPATOLOGY (2004)
Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes
M Tiikkainen et al.
DIABETES (2004)
A Pilot Study of Vitamin E Versus Vitamin E and Pioglitazone for the Treatment of Nonalcoholic Steatohepatitis
Arun J. Sanyal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Cytokines and NASH: A pilot study of the effects of lifestyle modification and vitamin E
M Kugelmas et al.
HEPATOLOGY (2003)
A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid
VN Santos et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2003)
Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study
S Merat et al.
JOURNAL OF HEPATOLOGY (2003)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
